GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Clicks Group Ltd (JSE:CLS) » Definitions » EV-to-EBITDA

Clicks Group (JSE:CLS) EV-to-EBITDA : 13.82 (As of May. 25, 2024)


View and export this data going back to 1996. Start your Free Trial

What is Clicks Group EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Clicks Group's enterprise value is R76,638 Mil. Clicks Group's EBITDA for the trailing twelve months (TTM) ended in Feb. 2024 was R5,546 Mil. Therefore, Clicks Group's EV-to-EBITDA for today is 13.82.

The historical rank and industry rank for Clicks Group's EV-to-EBITDA or its related term are showing as below:

JSE:CLS' s EV-to-EBITDA Range Over the Past 10 Years
Min: 10.71   Med: 15.64   Max: 25.12
Current: 13.83

During the past 13 years, the highest EV-to-EBITDA of Clicks Group was 25.12. The lowest was 10.71. And the median was 15.64.

JSE:CLS's EV-to-EBITDA is ranked worse than
54.29% of 466 companies
in the Healthcare Providers & Services industry
Industry Median: 12.715 vs JSE:CLS: 13.83

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-25), Clicks Group's stock price is R309.95. Clicks Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2024 was R11.031. Therefore, Clicks Group's PE Ratio for today is 28.10.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Clicks Group EV-to-EBITDA Historical Data

The historical data trend for Clicks Group's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clicks Group EV-to-EBITDA Chart

Clicks Group Annual Data
Trend Aug14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.79 14.27 18.20 14.13 12.78

Clicks Group Semi-Annual Data
Aug14 Feb15 Aug15 Feb16 Aug16 Feb17 Aug17 Feb18 Aug18 Feb19 Aug19 Feb20 Aug20 Feb21 Aug21 Feb22 Aug22 Feb23 Aug23 Feb24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 14.13 - 12.78 -

Competitive Comparison of Clicks Group's EV-to-EBITDA

For the Pharmaceutical Retailers subindustry, Clicks Group's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Clicks Group's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Clicks Group's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Clicks Group's EV-to-EBITDA falls into.



Clicks Group EV-to-EBITDA Calculation

Clicks Group's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=76638.101/5545.57
=13.82

Clicks Group's current Enterprise Value is R76,638 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Clicks Group's EBITDA for the trailing twelve months (TTM) ended in Feb. 2024 was R5,546 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Clicks Group  (JSE:CLS) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Clicks Group's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=309.95/11.031
=28.10

Clicks Group's share price for today is R309.95.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Clicks Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2024 was R11.031.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Clicks Group EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Clicks Group's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Clicks Group (JSE:CLS) Business Description

Traded in Other Exchanges
Address
Cnr Searle and Pontac Streets, PO Box 5142, Cape Town, ZAF, 8001
Clicks Group Ltd operates pharmaceutical health and beauty retail stores. The company primarily operates a retail pharmacy chain in South Africa, with a limited number of operations in bordering countries. The company targets middle- to upper-income consumers. Clicks' business strategy focuses on consistent product sourcing, product development, and measured store expansion. The company has a portfolio of retail franchise brands including The Body Shop, GNC, and claire's. Clicks uses United Pharmaceutical Distributors' capabilities for the groups' integrated channel to the healthcare market.